| 1 |
Li X, Wu Y, Sun X, Ma J, Li X, Liu C, et al. Non-O1/non-O139 Vibrio cholerae bacteraemia in mainland China from 2005 to 2019: clinical, epidemiological and genetic characteristics. Epidemiol Infect. 2020; 148: e186.
|
| 2 |
Špačková M, Košťálová J, Fabiánová K. Non-O1/non-O 139 vibrios - occurrence not only in Europe in recent years. Epidemiol Mikrobiol Imunol. 2021; 70(2): 131-8.
|
| 3 |
Maraki S, Christidou A, Anastasaki M, Scoulica E. Non-O1, non-O139 Vibrio cholerae bacteremic skin and soft tissue infections. Infect Dis (Lond). 2016; 48(3): 171-6.
|
| 4 |
Zhang QT, Alter T, Strauch E, Hammerl JA, Schwartz K, Borowiak M, et al. Genetic and phenotypic virulence potential of non-O1/non-O 139 Vibrio cholerae isolated from German retail seafood. Microorganisms. 2023; 11(11): 2751.
|
| 5 |
Chen YT, Tang HJ, Chao CM, Lai CC. Clinical manifestations of non-O1 Vibrio cholerae infections. PLoS One. 2015; 10(1): e0116904.
|
| 6 |
Baker-Austin C, Oliver JD, Alam M, Ali A, Waldor MK, Qadri F, et al. Vibrio spp. infections. Nat Rev Dis Primers. 2018; 4(1): 5.
|
| 7 |
Rodríguez JY, Duarte C, Rodríguez GJ, Montaño LA, Benítez-Peñuela MA, Díaz P, et al. Bacteremia by non-O1/non-O 139 Vibrio cholerae: case description and literature review. Biomedica. 2023; 43(3): 323-9.
doi: 10.7705/biomedica.6716
pmid: 37871571
|
| 8 |
Ramamurthy T, Nandy RK, Mukhopadhyay AK, Dutta S, Mutreja A, Okamoto K, et al. Virulence regulation and innate host response in the pathogenicity of Vibrio cholerae. Front Cell Infect Microbiol. 2020; 10: 572096.
|
| 9 |
Kim CS, Bae EH, Ma SK, Kim SW. Severe septicemia, necrotizing fasciitis, and peritonitis due to Vibrio vulnificus in a patient undergoing continuous ambulatory peritoneal dialysis: a case report. BMC Infect Dis. 2015; 15: 422.
|
| 10 |
Zhang XH, Lu YF, Qian HM, Liu GY, Mei YN, Jin F, et al. Non-O1, non-O139 139 Vibrio cholerae (NOVC) bacteremia: case report and literature review, 2015-2019. Infect Drug Resist. 2020; 13: 1009-16.
|
| 11 |
Negri M, Gona F, Tassan Din C, Raccagni AR, Bertoni C, Moro M, et al. Non-O1 and non-O139 Vibrio cholerae septicemia and cellulitis: a case report. New Microbiol. 2024; 47(2): 190-3.
|
| 12 |
Tsuruta K, Ueyama T, Watanabe T, Nakano K, Uno K, Fukushima H. Intensive care management of a patient with necrotizing fasciitis due to non-O1/O139 Vibrio cholerae after traveling to Taiwan : a case report. BMC Infect Dis. 2020; 20(1): 618.
|
| 13 |
Wong KC, Brown AM, Luscombe GM, Wong SJ, Mendis K. Antibiotic use for Vibrio infections: important insights from surveillance data. BMC Infect Dis. 2015; 15: 226.
|
| 14 |
Lu WJ, Hsu PH, Lin HV. A novel cooperative metallo-β-lactamase fold metallohydrolase from pathogen Vibrio vulnificus exhibits β-lactam antibiotic-degrading activities. Antimicrob Agents Chemother. 2021; 65(9): e0032621.
|
)
